Search Results - "Moiseenko, F."

Factors associated with the efficacy of aflibercept in patients with metastatic colorectal cancer: results of the multicenter observational study by Fedyanin, M., Chubenko, V., Belonogov, A., Beluhin, S., Belyaeva, A., Bolotina, L., Vladimirova, L., Zhabina, A., Zagorskaya, L., Khalikova, L., Fakhrudinova, O., Moiseenko, F., Khasanova, A., Musaeva, H., Novikova, O., Stradaeva, I., Mukhametshina, G., Orlova, R., Micshenko, A., Popova, I., Mukova, L., Kertiev, B.

Get full text

Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome by Moiseenko, F.V., Volkov, N.M., Zhabina, A.S., Stepanova, M.L., Rysev, N.A., Klimenko, V.V., Myslik, A.V., Artemieva, E.V., Egorenkov, V.V., Abduloeva, N.H., Ivantsov, A.O., Kuligina, E.S., Imyanitov, E.N., Moiseyenko, V.M.

“…The aim of our trial was to evaluate the prognostic significance of qualitative ctDNA analysis on different stages of EGFR mutated non-small cell lung cancer…”
Get full text

CELLULAR IMMUNE REACTION IN A GREAT OMENTUM WITH METASTASES IN PATIENTS WITH OVARIAN CANCER by Khalikova, L. V., Moiseenko, F. V.

“…Introduction . Ovarian cancer is characterized by complex diagnostics and flow forecasting, which makes it important to search for prognostic criteria…”
Get full text

Assessment of the effectiveness of surgical resections following tyrosine kinase inhibitor therapy in patients with EGFR-mutated stage III–IV lung adenocarcinoma by Levchenko, E. V., Moiseenko, F. V., Orlov, S. V., Imyanitov, E. N., Mikhnin, A. E., Gelfond, M. L., Slugin, E. N., Ergnyan, S. M., Levchenko, N. E., Zhabina, A. S., Ulitin, A. M., Mamontov, O. Yu, Lopushanskaya, O. O., Artemeva, E. V., Murtazin, A. I., Shabinskaya, V. I.

“…Objective. To assess the overall and disease-free survival rates in patients with EGFR-mutated lung adenocarcinoma, who underwent surgery after achieving the…”
Get full text

Effect of silver oxide nanoparticles on tumor growth in vivo by Rutberg, F. G., Dubina, M. V., Kolikov, V. A., Moiseenko, F. V., Ignat’eva, E. V., Volkov, N. M., Snetov, V. N., Stogov, A. Yu

“…A study investigated the antitumor properties of aqueous dispersions of silver oxide nanoparticles in experiments with rats with Pliss lymphosarcoma…”
Get full text

Bladder cancer. A retrospective analysis of the use of vinfluvin in real clinical practice by A. S. Zhabina, A. I. Novikov, F. V. Moiseenko, N. M. Volkov, E. O. Stepanova, E. V. Artemeva, N. H. Abduloeva, V. M. Moiseenko

“…Purpose of the study. There is the generalized analysis of administration of vinflunine in real clinical practice in St.Petersburg Clinical Scientific and…”
Get full text

Efficacy of Videoendoscopic Inguinal Femoral Lymphadenectomy for Management of Metastatic Skin Melanoma by Egorenkov, V. V., Moiseenko, F. V., Volkov, N. M., Molchanov, M. S., Ravkina, M. S., Abduloeva, N. Kh, Linets, A. V., Khairutdinov, V. R., Ibragimov, A. M., Moiseyenko, V. M.

“…Aim. Assessment of the utility and advantage of videoendoscopic inguinal femoral lymphadenectomy (VE-LAD) over the standard open technique (OLAD) in patients…”
Get full text

Incidence of Synchronous Multiple Primary Melanoma in Patients with Solitary Melanoma: a Prospective Comparative Study by Egorenkov, V. V., Moiseenko, F. V., Volkov, N. M., Molchanov, M. S., Ravkina, M. S., Abduloeva, N. Kh, Linets, A. V., Khairutdinov, V. R., Aksenov, M. S., Moiseyenko, V. M.

“…Background. Malignant melanoma is steadily exaggerating over the recent decades. Nonetheless, improved systemic therapies have substantially increased life…”
Get full text

Comprehensive Screening for COVID-19 at St. Petersburg Oncology Centre by Volkov, N. M., Lebedeva, M. S., Egorenkov, V. V., Moiseenko, F. V., Abduloeva, N. Kh, Bogdanov, A. A., Terterov, I. N., Chernobrivceva, V. V., Valeeva, N. E., Myasnikova, E. B., Navatskaya, A. S., Bogdanov, A. A., Moiseyenko, V. M.

“…Background. Clinical reports on the coronavirus disease 2019 (COVID-19) suggest its higher incidence and worse outcomes in cancer patients. Considering a rapid…”
Get full text

Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer by Fedyanin, M. Yu, Moiseenko, F. V., Chekini, D. A., Chubenko, V. A., Zhabina, A. S., Zagorskaya, L. A., Kramchaninov, M. M., Tjulandin, S. A., Moiseyenko, V. M.

“…Introduction. Trifluridine/Tipiracil (FTD/TPI) is a new chemotherapeutic drug approved in more than 60 countries for use in patients with metastatic colorectal…”
Get full text

Mineralization of the Peritoneum — a New Target in the Treatment of Peritoneal Carcinomatosis by Gantsev, Sh. Kh, Moiseenko, V. M., Gantsev, K. Sh, Solomenny, S. V., Kzyrgalin, Sh. R., Dokichev, V. A., Moiseenko, F. V., Minigazimov, R. S.

“…Introduction. This article presents data on the manifestations of changes in the microenvironment of the peritoneal cavity in patients with carcinomatosis,…”
Get full text

Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer by Semiglazova, T. Yu, Lubennikova, E. V., Bolotina, L. V., Orlova, R. V., Moiseenko, F. V., Avramenko, A. V., Artemeva, E. V., Borozdina, S. A., Vakhitova, A. A., Volkov, N. M., Ganshina, I. P., Dzhalilova, Sh. A., Zhukova, L. G., Kasparov, B. S., Kachmazov, A. A., Klimenko, V. V., Kornietskaya, A. I., Meshcheryakov, A. A., Paichadze, A. A., Poltoratsky, A. N., Ryabishina, O. E., Stepanova, M. L., Imyanitov, E. N

“…Introduction. The presence of a germinal BRCA mutation occurs in 3–4% of all breast cancer (BC) patients with various biological subtypes, but significantly…”
Get full text

Molecular genetic studies of glial tumors in children by Soltan, P. S., Moiseenko, F. V., Ochkolyas, V. N., Startsev, V. Yu

“…Glioblastomas are the most frequent malignant neoplasm among primary brain tumors of childhood. Despite the advances in a multimodality treatment approach…”
Get full text

Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer by Frolova, M A, Kochetkova, Ya I, Chubenko, V A, Volkov, N M, Moiseenko, F V, Garmarnik, T V, Ponomarenko, D M, Orlov, A E, Kostalanova, Yu V, Makarycheva, Yu Yu, Nizegorodzeva, A A

“…The article represents case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone…”
Get full text

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study by Pokataev, I. A., Lyadova, M. A., Fedyanin, M. Yu, Tryakin, A. A., Chubenko, V. F., Moiseenko, F. V., Zagorskaya, L. A., Stepanova, M. L., Androsova, A. V., Nosov, D. A., Karpova, N. V., Kit, O. I., Vladimirova, L. Yu, Popova, I. L., Belonogov, A. V., Ponomarenko, D. M., Yukalchuk, D. Yu, Shikina, V. E., Ivanova, N. V., Khasanova, A. I., Kruglov, A. D., Stradaeva, I. Yu, Perepletova, A. S., Filippova, V. M., Buzova, N. L., Khavaneva, O. V., Musaeva, Kh. S., Goryainova, A. Yu, Romanchuk, O. V., Tespizhek, I. Sh, Tyulyandin, S. A.

“…Introduction. The randomized MPACT study showed that nab-paclitaxel plus gemcitabine results in statistically significantly longer life expectancy. The…”
Get full text

Dynamics of ctDNA in patients with NSCLC by Zhabina, A.S., Mjslik, A., Moiseenko, F., Moiseenko, V., Stepanova, M.

Get full text

137P Trial comparing the safety, efficacy and immunogenicity of trastuzumab biosimilar candidate (TX05) with originator trastuzumab in HER2+ early breast cancer by Krivorotko, P., Manikhas, A., Moiseenko, F., Poddubskaya, E., Neciosup, S.P., Gopichand, M., Osynskyi, D., Haynes, T., Lai, J., Mills, B.J.

Get full text

75PDynamics of ctDNA in patients with NSCLC by Zhabina, A S, Mjslik, A, Moiseenko, F, Moiseenko, V, Stepanova, M

“…Abstract Background For many years, researchers have tried to find more effective ways to find out if a person has cancer, and find it at an early stage, when…”
Get full text

MO31-2 Telisotuzumab vedotin monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer by Horinouchi, Hidehito, Goldman, J.W., Moiseenko, F., Cicin, I., Filippova, E., Bar, J., Tomasini, P., Ocampo, C., Sullivan, D., Maag, D., Motwani, M., Jin, J., Camidge, D.R.

Get full text

100P Physician perceptions of testing practices in patients with early and advanced stage EGFR mutation-positive (EGFRm) NSCLC: A global survey by Bailey, T., Moiseenko, F., Paats, M.S., Demedts, I., Erman, M., Kahangire, D.A., Kozlov, V., Mark, M., Minatta, J., Rajappa, S., Zukin, M., Madondo, M., Taylor, A., Samol, J.

Get full text